1. Home
  2. VIR vs MVST Comparison

VIR vs MVST Comparison

Compare VIR & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$7.21

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Microvast Holdings Inc.

MVST

Microvast Holdings Inc.

HOLD

Current Price

$2.54

Market Cap

987.8M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIR
MVST
Founded
2016
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
987.8M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
VIR
MVST
Price
$7.21
$2.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
1
Target Price
$28.63
$6.00
AVG Volume (30 Days)
1.9M
4.1M
Earning Date
02-25-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,860,000.00
$444,504,000.00
Revenue This Year
N/A
$24.19
Revenue Next Year
N/A
$17.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.82
52 Week Low
$4.16
$1.09
52 Week High
$10.67
$7.12

Technical Indicators

Market Signals
Indicator
VIR
MVST
Relative Strength Index (RSI) 53.96 34.07
Support Level $6.86 $2.32
Resistance Level $7.97 $3.16
Average True Range (ATR) 0.50 0.17
MACD -0.03 -0.04
Stochastic Oscillator 64.40 19.76

Price Performance

Historical Comparison
VIR
MVST

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About MVST Microvast Holdings Inc.

Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.

Share on Social Networks: